PT  - JOURNAL ARTICLE
AU  - Felix Poppelaars
AU  - Mariana Gaya da Costa
AU  - Bernardo Faria
AU  - Siawosh K. Eskandari
AU  - Jeffrey Damman
AU  - Marc A. Seelen
TI  - A functional <em>TGFB1</em> polymorphism in the donor associates with long-term graft survival after kidney transplantation
AID  - 10.1101/2021.07.05.21260045
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.05.21260045
4099  - http://medrxiv.org/content/early/2021/08/27/2021.07.05.21260045.short
4100  - http://medrxiv.org/content/early/2021/08/27/2021.07.05.21260045.full
AB  - Introduction Improvement of long-term outcomes in kidney transplantation remains one of the most pressing challenges, yet drug development is stagnating. Human genetics offers an opportunity for much-needed target validation in transplantation. Conflicting data exist about the effect of transforming growth factor-beta 1 (TGF-β1) on kidney transplant survival since TGF-β1 has pro-fibrotic and protective effects. We investigated the impact of a recently discovered functional TGBF1 polymorphism on kidney graft survival.Methods We performed an observational cohort study analyzing recipient and donor DNA in 1,271 kidney transplant-pairs from the University Medical Center Groningen in The Netherlands and associated a low-producing TGBF1 polymorphism (rs1800472-C>T) with 5, 10, and 15-year death-censored kidney graft survival.Results Donor genotype frequencies of rs1800472 in TGBF1 differed significantly between patients with and without graft loss (P=0.014). Additionally, the low-producing TGBF1 polymorphism in the donor was associated with an increased risk of graft loss following kidney transplantation (HR 2.12 for the T-allele; 95%-CI 1.18–3.79; P=0.012). The incidence of graft loss within 15 years of follow-up was 16.4% in the CC-genotype group and 31.6% in the CT-genotype group. After adjustment for transplant-related covariates, the association between the TGBF1 polymorphism in the donor and graft loss remained significant. In contrast, there was no association between the TGBF1 polymorphism in the recipient and graft loss.Conclusion Kidney allografts possessing a low-producing TGBF1 polymorphism have a higher risk of late graft loss. Our study adds to a growing body of evidence that TGF-β1 is beneficial, rather than harmful, for kidney transplant survival.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was financially supported by the Graduate School of Medical Sciences of the University of Groningen.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The medical ethics committee of the University Medical Center Groningen approved the study under file number METc 2014 077.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request.BPARBiopsy-proven acute rejectionCITCold ischemia timeDBDDonation after circulatory deathDCDDonation after brain deathDGFDelayed graft functionESKDEnd-stage kidney diseaseHLAHuman leukocyte antigenHRHazard ratioPRAPanel-reactive antibodySMADSmall mothers against decapentaplegic homologueSNPSingle-nucleotide polymorphismTGF-βTransforming growth factor betaTGF-β1Transforming growth factor beta 1TGFB1Transforming growth factor beta 1 geneWITWarm ischemia time